HIF1A and ischemia: CoCl2 treatment causes hypoxia, a key event during IRI, to alter gene and protein expression similarly to ischemia [29], which induces hypoxia by blocking the degradation of HIF-1α and enhancing subsequent HIF-1α accumulation [31].